DocGo secures two-year transportation contract renewal with major Tennessee healthcare system
Seeking Alpha News (Tue, 10-Dec 10:32 AM ET)
DocGo Secures Two-Year Transportation Contract Renewal with Major Tennessee Healthcare System
Business Wire (Tue, 10-Dec 7:35 AM ET)
Business Wire (Wed, 4-Dec 7:35 AM ET)
Business Wire (Tue, 26-Nov 7:35 AM ET)
DocGo Announces Participation at Three Upcoming Investor Conferences
Business Wire (Mon, 18-Nov 7:35 AM ET)
DocGo Announces Third Quarter 2024 Results
Business Wire (Thu, 7-Nov 4:05 PM ET)
Kuehn Law Encourages Investors of DocGo, Inc. to Contact Law Firm
PRNewswire (Thu, 31-Oct 12:40 PM ET)
DocGo to Announce Third Quarter 2024 Results on Thursday, November 7, 2024
Business Wire (Mon, 21-Oct 7:35 AM ET)
Ambulnz by DocGo and Bayhealth Renew Partnership in Delaware, Extending Contract for Three Years
Business Wire (Wed, 9-Oct 7:35 AM ET)
DocGo Appoints Healthcare Visionary Dr. Stephen K. Klasko as Chair of the Board
Business Wire (Mon, 30-Sep 7:35 AM ET)
DocGo Inc is a provider of last-mile mobile health services and integrated medical mobility solutions. The company has three reportable segments: Mobile Health Services, Transportation Services, and Corporate. Mobile Health Services is the key revenue-generating segment for the company.
Docgo trades on the NASDAQ stock market under the symbol DCGO.
As of December 12, 2024, DCGO stock price climbed to $4.19 with 864,679 million shares trading.
DCGO has a beta of 0.12, meaning it tends to be less sensitive to market movements. DCGO has a correlation of 0.00 to the broad based SPY ETF.
DCGO has a market cap of $425.40 million. This is considered a Small Cap stock.
Last quarter Docgo reported $139 million in Revenue and $.05 earnings per share. This beat revenue expectation by $805,000 and met earnings estimates .
In the last 3 years, DCGO traded as high as $11.41 and as low as $2.75.
The top ETF exchange traded funds that DCGO belongs to (by Net Assets): IWM, VTI, VXF, IWN, SCHA.
DCGO has underperformed the market in the last year with a price return of -20.8% while the SPY ETF gained +32.3%. However, in the short term, DCGO had mixed performance relative to the market. It has outperformed in the last 3 months, returning +18.4% vs +9.3% return in SPY. But in the last 2 weeks, DCGO shares have been beat by the market, returning -4.3% compared to an SPY return of +0.9%.
DCGO support price is $4.00 and resistance is $4.28 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that DCGO shares will trade within this expected range on the day.